Funding for this research was provided by:
Health Commission of Hunan Province (20201907)
Received: 7 May 2022
Accepted: 6 December 2022
First Online: 17 December 2022
: The protocol for the study was approved by the ethics committee of the First Affiliated Hospital of University of South China. Each author certifies that all investigations were conducted in conformity with ethical principles. All participants provided informed consent before their participation in the study and written were obtained from all participants.This randomized, prospective, and controlled trial was listed in the Chinese Clinical Trial Registry <b>(ChiCTR1900024235)</b>. All procedures involving humans were performed in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Reported trial data complied with the Consolidated Standards of Reporting Trials (CONSORT) statement.
: Not Applicable.
: There were no potential conflicts of interest of all authors.